Peer-reviewed literature doesnt focus on large-scale randomized controlled trials in humans and, because of this, human evidence is limited
PubChem Compound Summary for CID 9941957, BPC-157 (C 62 H 98 N 16 O 22 , avg 1,419.5 g/mol, monoisotopic 1,418.70415882 Da, CAS 137525-51-0)
This dose range supports muscle retention and enhanced fat loss while keeping risks manageable
This medication also has important protective benefits
Endogenous plasma concentrations decline from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60, a reduction that correlates with diminished tissue remodeling capacity
Targeting PPAR in the rat valproic acid model of autism: focus on social motivational impairment and sex-related differences